Private Equity
Advent International has agreed to acquire Bharat Serums, a India-based biopharmaceutical company focused on women's healthcare. No financial terms were disclosed. As a result of this transaction, OrbiMed PE and Kotak PE will exit their investments in BSV. Innergize Solutions acted as strategic adviser to BSV on the deal.
4 min read · 18 November 2019
StimAire, a medical device company focused on treating sleep apnea, has secured an undisclosed amount of funding. The investor was UAVenture Capital Fund.
1 min read · 18 November 2019
Toronto-based Winterlight Labs Inc, a developer of artificial intelligence to help healthcare professionals assess and analyze patients' cognitive health, has secured C$5.6 million in funding. Hikma Ventures, the venture capital arm of Hikma Pharmaceuticals PLC, led the round. Other investors that participated in the round included First Star Ventures, Pacific Health Ventures and Grey Sky Venture Partners.
1 min read · 18 November 2019
Kohlberg & Co is evaluating the sale of SpecialtyCare, an outsourced provider of intraoperative neuromonitoring and other operating room services, according to three sources.
2 min read · 18 November 2019
Roche has agreed to acquire Lexington, Massachusetts-based Promedior, a biotech company. According to terms of the agreement, Roche will make an upfront cash payment of $390 million. Promedior's backers include Morgenthaler Ventures, HealthCare Ventures, Forbion, Easton Capital, Fibrotec Ventures and Polaris Partners.
5 min read · 15 November 2019
South San Francisco-based X-37 LLC, an artificial intelligence-enabled drug discovery company, has secured $14.5 million in Series A financing. DCVC Bio led the round with participation from Alpha Intelligence Capital and Hemi Ventures.
1 min read · 14 November 2019
FFL Partners has made an investment in Grand Rapids, Michigan-based Orthodontic Partners LLC, an orthodontic services company. No financial terms were disclosed.
3 min read · 14 November 2019
The transaction brings OCP’s revenues to approximately $125 million, and on the basis of earnings makes it one of the largest PE-backed orthopedic companies in the country
3 min read · 14 November 2019
Merck has acquired Calporta Therapeutics, a portfolio company of COI Pharmaceuticals, which is backed by Avalon Ventures. The purchase price was $576 million. Calporta is developing selective small molecule agonists of TRPML1.
3 min read · 13 November 2019
2 min read · 12 November 2019
